NRXS Overview

Company Profile

Related stocks

CBIO • United States

Crescent Biopharma, Inc.

14.91 USD

553.86M USD 1Y +17.1%

CRMD • United States

CorMedix Inc.

7.38 USD

575.23M USD 1Y -35%

MNPR • United States

Monopar Therapeutics Inc.

78.96 USD

529.99M USD 1Y -14.8%

PBYI • United States

Puma Biotechnology Inc

10.29 USD

531.17M USD 1Y +90.6%

OABI • United States

OmniAb, Inc.

4.79 USD

696.42M USD 1Y +166.3%

RGNX • United States

REGENXBIO Inc.

8.07 USD

532.73M USD 1Y -33.8%

ANNX • United States

Annexon, Inc.

4.02 USD

762.11M USD 1Y +27%

SGP • United States

SpyGlass Pharma, Inc.

24.92 USD

833.52M USD

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile

4 Metrics

Country

Region

Sector

Industry

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High

3Y Volatility

92.1% p.a.

Max Drawdown (3Y)

-57.9%

Sharpe Ratio (3Y)

0.23

Beta Factor

1.36

Size Class

Micro Cap

Notes & Warnings

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Exemplary balance sheet strength: Very solid ratio of equity to debt.

🔴 Low analyst coverage – higher uncertainty in growth estimates & projections